Status:
COMPLETED
Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Covid19
Vaccine Reaction
Eligibility:
FEMALE
18-45 years
Brief Summary
Coronavac, one of the vaccines developed within the scope of combating the COVID-19 pandemic that has surrounded the world for a year, started to be applied in the first healthcare workers in our coun...
Detailed Description
The survey contains 20 questions aimed at obtaining information about the menstrual cycles of health workers before and after vaccination. Demographic data of the participants are also taken.
Eligibility Criteria
Inclusion
- be positive for covid-19 (severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 )
- Having 1 or 2 doses of vaccine
- have menstruation
- Being a female health worker
- not using drugs that can affect menstruation
Exclusion
- be negative for covid-19(severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 )
- have no menstruation
- Being a male health worker
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 9 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04854408
Start Date
March 18 2021
End Date
May 9 2021
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye), 34000